医药前沿-话题@MedSci

[GetTopicListResponse(id=1084158, encodeId=119d108415802, content=<a href='/topic/show?id=2506104439d9' target=_blank style='color:#2F92EE;'>#医药前沿#</a> , objectTitle=NEJM：早期瑞德西韦治疗可使新冠肺炎患者住院风险降低87%, objectType=article, longId=292734, objectId=ffb5292e342a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211224/1640341743809_2051781.jpg, objectUrl=/article/show_article.do?id=ffb5292e342a, replyNumber=0, likeNumber=67, createdTime=2021-12-25, rootId=0, userName=Dr.Frank, userId=e6408384, projectId=1, avatar=, status=1, hasArticle=1, attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20211225/a247b55d66844be0bb549413c0a864a5.jpg, type=image, width=554, height=318)], ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffb5292e342a, moduleTitle=NEJM：早期瑞德西韦治疗可使新冠肺炎患者住院风险降低87%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffb5292e342a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1083788, encodeId=3cda1083e88b8, content=<a href='/topic/show?id=2506104439d9' target=_blank style='color:#2F92EE;'>#医药前沿#</a>, objectTitle=Clin Transl Med：中国科学家团队发现黄芩素有望用于结直肠癌的新型靶向疗法, objectType=article, longId=292617, objectId=014029261e1d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20211221/da09bf03c0144ba7b8bfa2998dae202b.jpg, objectUrl=/article/show_article.do?id=014029261e1d, replyNumber=0, likeNumber=77, createdTime=2021-12-24, rootId=0, userName=Dr.Frank, userId=e6408384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=014029261e1d, moduleTitle=Clin Transl Med：中国科学家团队发现黄芩素有望用于结直肠癌的新型靶向疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=014029261e1d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1083634, encodeId=a7c110836343e, content=<a href='/topic/show?id=2506104439d9' target=_blank style='color:#2F92EE;'>#医药前沿#</a>一项针对R/R 大B细胞淋巴瘤的临床试验中，CAR-T细胞治疗相较于标准挽救性化疗显著延长患者的无事件生存期。该研究发表在本月初的新英格兰医学上。#ASH21 nej.md/3oAsTFA, objectTitle=医药前沿, objectType=topic, longId=104439, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=37, createdTime=2021-12-23, rootId=0, userName=Dr.Frank, userId=e6408384, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1083548, encodeId=bee9108354803, content=<a href='/topic/show?id=2506104439d9' target=_blank style='color:#2F92EE;'>#医药前沿#</a> , objectTitle=J Hepatol: Atezolizumab联合贝伐珠单抗vs索拉非尼治疗不可切除肝细胞癌的疗效更新：IMbrave150, objectType=article, longId=292266, objectId=82df292266f0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211219/1639922447630_1611618.png, objectUrl=/article/show_article.do?id=82df292266f0, replyNumber=0, likeNumber=54, createdTime=2021-12-23, rootId=0, userName=Dr.Frank, userId=e6408384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82df292266f0, moduleTitle=J Hepatol: Atezolizumab联合贝伐珠单抗vs索拉非尼治疗不可切除肝细胞癌的疗效更新：IMbrave150, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82df292266f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1083544, encodeId=2c86108354469, content=<a href='/topic/show?id=2506104439d9' target=_blank style='color:#2F92EE;'>#医药前沿#</a>, objectTitle=NEJM：佩索利单抗治疗全身性脓疱型银屑病的疗效如何？, objectType=article, longId=292599, objectId=30342925991e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211223/1640218294924_1739456.jpg, objectUrl=/article/show_article.do?id=30342925991e, replyNumber=0, likeNumber=58, createdTime=2021-12-23, rootId=0, userName=Dr.Frank, userId=e6408384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30342925991e, moduleTitle=NEJM：佩索利单抗治疗全身性脓疱型银屑病的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30342925991e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] Dr.Frank

医药前沿

2021-12-23

Dr.Frank (审核中...)

前往app查看评论内容

#医药前沿#

NEJM：早期瑞德西韦治疗可使新冠肺炎患者住院风险降低87%

2021-12-25

Dr.Frank (审核中...)

前往app查看评论内容

#医药前沿#

Clin Transl Med：中国科学家团队发现黄芩素有望用于结直肠癌的新型靶向疗法

2021-12-24

Dr.Frank (审核中...)

前往app查看评论内容

#医药前沿#一项针对R/R 大B细胞淋巴瘤的临床试验中，CAR-T细胞治疗相较于标准挽救性化疗显著延长患者的无事件生存期。该研究发表在本月初的新英格兰医学上。#ASH21 nej.md/3oAsTFA

2021-12-23

Dr.Frank (审核中...)

前往app查看评论内容

#医药前沿#

J Hepatol: Atezolizumab联合贝伐珠单抗vs索拉非尼治疗不可切除肝细胞癌的疗效更新：IMbrave150

2021-12-23

Dr.Frank (审核中...)

前往app查看评论内容

#医药前沿#

NEJM：佩索利单抗治疗全身性脓疱型银屑病的疗效如何？

2021-12-23

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

#医药前沿#

科室

工具

服务